(Q35059070)

6 August 2017

1 reference

title

Quality of life in patients with advanced colorectal cancer: what has been learnt? (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

Conroy T

1

1 reference

6 August 2017

Bleiberg H

series ordinal

2

1 reference

6 August 2017

Glimelius B

series ordinal

3

1 reference

6 August 2017

publication date

1 February 2003

1 reference

European Journal of Cancer

6 August 2017

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

287-294

1 reference

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Quality of life in patients with metastatic colorectal cancer receiving chemotherapy: a randomized, double-blind trial comparing 5-FU versus 5-FU with leucovorin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Baseline quality of life predicts survival in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Compliance in quality of life data: a Norwegian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900664-0

7 January 2021

10.1016/S0959-8049(02)00664-0

Identifiers

DOI

1 reference

6 August 2017

1 reference